✦ LIBER ✦

PUK28 LONG-TERM DARIFENACIN TREATMENT FOR OVERACTIVE BLADDER: QUALITY OF LIFE OUTCOMES FROM A 2-YEAR, OPEN-LABEL EXTENSION STUDY

✍ Scribed by J Young; K Lheritier; M Steel; P Dwyer

Book ID: 118607674
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 81 KB
Volume: 8
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)67404-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term treatment with darifenacin for

Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study

✍ François Haab; Jacques Corcos; Paul Siami; Karin Glavind; Peter Dwyer; Michael S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

LONG-TERM TREATMENT OF OVERACTIVE BLADDE

LONG-TERM TREATMENT OF OVERACTIVE BLADDER WITH DARIFENACIN IN OLDER PATIENTS: ANALYSIS OF RESPONDER RATES IN A 2-YEAR, OPEN-LABEL EXTENSION STUDY

✍ F. Haab; S. Hill; K. Lheritier; F.T. Kawakami; M. Gittelman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Long-term benefits of darifenacin treatm

Long-term benefits of darifenacin treatment for patient quality of life: Results from a 2-year extension study

✍ Peter Dwyer; Con Kelleher; Jay Young; François Haab; Karine Lheritier; Rinat Ari 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 1 views

Sustained improvement in patient-reporte

Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open-label extension studies

✍ Con J. Kelleher; Roger R. Dmochowski; Sandra Berriman; Zoe S. Kopp; Martin Carls 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB

Solifenacin treatment for overactive bla

Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare® Open-Label Trial

✍ J. P. Capo’ Jr; C. Laramée; V. Lucente; A. Fakhoury; S. Forero-Schwanhaeuser 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB